USNA.NYSEUsana Health Sciences INC

Form 4: USANA Health Sciences Director Acquires Restricted Stock Units

Sentiment:

SEC Form 4

📋All filings for Usana Health Sciences INC
🔒Login to Follow

Director John Turman Fleming acquired 2,697 restricted stock units in USANA Health Sciences on May 2, 2024, according to a Form 4 filing.

Summary

  • On May 2, 2024, John Turman Fleming, a director of USANA Health Sciences Inc., acquired 2,697 restricted stock units (RSUs).
  • Each RSU represents a contingent right to receive one share of USNA common stock.
  • The RSUs vest in four equal installments: 25% on August 2, 2024, November 2, 2024, February 2, 2025, and May 2, 2025.
  • Following the transaction, Fleming directly owns 2,697 derivative securities.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a standard transaction of restricted stock units, which is a common form of executive compensation.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a director's acquisition of restricted stock units, which is a common form of executive compensation.

Stakeholder Impact

  • The acquisition of restricted stock units by a director aligns the director's interests with those of the shareholders, as the value of the units is tied to the company's stock performance.

Key Dates

DateDescription
05/02/2024Date of transaction: John Turman Fleming acquired 2,697 restricted stock units.
08/02/2024First vesting date: 25% of the restricted stock units vest.
11/02/2024Second vesting date: 25% of the restricted stock units vest.
02/02/2025Third vesting date: 25% of the restricted stock units vest.
05/02/2025Final vesting date: 25% of the restricted stock units vest.
05/03/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.